Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Cost Effectiveness | 1 |
| Drug Therapy | 1 |
| Equipment | 1 |
| Evidence | 1 |
| Financial Support | 1 |
| Industry | 1 |
| Medical Education | 1 |
| Medical Services | 1 |
| Organizations (Groups) | 1 |
| Partnerships in Education | 1 |
| Pharmaceutical Education | 1 |
| More ▼ | |
Source
| Journal of Continuing… | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Descriptive | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkWolfrey, Jeff; Brown, Steven R.; Ebell, Mark H.; Geng, Jamie – Journal of Continuing Education in the Health Professions, 2012
Concerns about the influence of the pharmaceutical and medical device industries on continuing medical education (CME) have been voiced frequently over the past decade. Reliance on industry funding increases the potential for bias. Industry-supported CME often emphasizes conditions that can be treated with newer drugs or devices rather than those…
Descriptors: Evidence, Public Health, Medical Education, Industry
